anmelden
OMX Nordic 40
2.716,67
PKT
+4,97
PKT
+0,18
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.09.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 30.09.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 27.09.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 24.09.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 23.09.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 23.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 23.09.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 23.09.19 | Novo Nordisk Reduce | HSBC | |
| 20.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.09.19 | Novo Nordisk Halten | Independent Research GmbH | |
| 20.09.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 19.09.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 17.09.19 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 17.09.19 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 17.09.19 | Hennes Mauritz (H M, H&M) Hold | Kepler Cheuvreux | |
| 17.09.19 | Hennes Mauritz (H M, H&M) Hold | HSBC | |
| 16.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.09.19 | Volvo (B) Underweight | Morgan Stanley | |
| 13.09.19 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
| 13.09.19 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 13.09.19 | AstraZeneca overweight | Barclays Capital | |
| 12.09.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.09.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 10.09.19 | AstraZeneca Sell | UBS AG | |
| 10.09.19 | Nokia Outperform | Credit Suisse Group | |
| 09.09.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 09.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.09.19 | Novo Nordisk Outperform | Bernstein Research | |
| 09.09.19 | AstraZeneca buy | Deutsche Bank AG | |
| 09.09.19 | A.P. Moeller - Maersk A-S (B) buy | Jefferies & Company Inc. | |
| 06.09.19 | AstraZeneca overweight | Barclays Capital | |
| 06.09.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.09.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 05.09.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 02.09.19 | Novo Nordisk buy | UBS AG |
